New Atmosphere, New Vision: Gibson and Whittemore Kick Off Invest in ME Conference 2016
Mark Berry reports on Dr. Gibson's introduction and Dr. Whittemore's keynote speech, at the 11th Invest in ME International ME Conference in London.
Discuss the article on the Forums.

We May Have Finally Discovered The Trigger That Starts Autoimmune Diseases

Discussion in 'Other Health News and Research' started by BurnA, Sep 2, 2017.

  1. BurnA

    BurnA Senior Member

    Messages:
    2,086
    Likes:
    9,863


    http://www.sciencealert.com/we-may-have-found-how-runaway-train-autoimmune-diseases-get-started

     
  2. Webdog

    Webdog Senior Member

    Wasn't it Mario Capecchi at the Stanford Symposium who emphasized the importance of developing a mouse model for ME/CFS?
     
    ahmo, GreyOwl and Rick Sanchez like this.
  3. Alvin2

    Alvin2 If humans were rational...

    Messages:
    1,308
    Likes:
    3,656
    Very interesting.
    What happens long term, the short term memory may be great to knock out (with Rituximab?) but if there is a long term we would need to fix it because it usually takes years to get diagnosed with ME/CFS or presumably most autoimmune diseases.

    Could this even explain why only 60% remission is achieved in Rituximab trials?
     
  4. TrixieStix

    TrixieStix Senior Member

    Messages:
    531
    Likes:
    879
    Woolie, pattismith and Hutan like this.
  5. Snow Leopard

    Snow Leopard Hibernating

    Messages:
    4,615
    Likes:
    12,454
    South Australia
    There doesn't seem to be any substantial evidence of this in humans though - each autoimmune disease seems to have it's own specific autoantibodies, rather than some generalised lack of B-Cell tolerance.
     
    MeSci likes this.
  6. alex3619

    alex3619 Senior Member

    Messages:
    12,523
    Likes:
    35,227
    Logan, Queensland, Australia
    This is the first study I have seen with this kind of specific claim. Its interesting. Its also a long way to go before we have clinical application.

    It might explain the Rituximab successes and failures. Might. So might other things. In ten or twenty years people will look back and ask why the answer is not obvious. We are mired in both a sea of uncertainty and quagmires of unfounded certainty. Or to put it another way, a lack of research and too much dogma.

    In less than two months we might have early word, however brief, on how Rituximab is doing.
     
    ahmo, Invisible Woman and BurnA like this.
  7. geraldt52

    geraldt52 Senior Member

    Messages:
    399
    Likes:
    1,549

See more popular forum discussions.

Share This Page